透过君实生物三季报,我们看到了寒冬中的那抹暖阳

钛媒体APP
30 Oct 2024

全文3414字,阅读约需10分钟,帮我划重点划重点01君实生物三季报显示,营收增速明显加快,抗风险能力显著增强,但股价仍受市场偏见影响。02公司核心产品特瑞普利单抗持续放量,海外市场放量成为新的业绩增量。03除此之外,君实生物在研管线矩阵丰富,JS004和JS005等潜力管线有望在未来两年内获批上市。04由于市场偏见,君实生物股价长期表现将围绕企业基本面中枢波动,有望回归合理水平。以上内容由腾讯...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10